MARKET

SLP

SLP

Simulations Plus Inc
NASDAQ
38.68
-0.52
-1.33%
After Hours: 38.68 0 0.00% 16:03 12/01 EST
OPEN
38.77
PREV CLOSE
39.20
HIGH
39.43
LOW
38.08
VOLUME
152.69K
TURNOVER
0
52 WEEK HIGH
52.69
52 WEEK LOW
32.38
MARKET CAP
771.22M
P/E (TTM)
79.47
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at SLP last week (1120-1124)?
Weekly Report · 6d ago
Weekly Report: what happened at SLP last week (1113-1117)?
Weekly Report · 11/20 09:22
Simulations Plus Inc: Current report
Press release · 11/18 20:13
Conestoga Capital Advisors Q3 2023 Commentary
Equity markets declined in q3 2023 as concerns over higher interest rates and a potential recession grew. Large-cap tech stocks outperformed small-cap stocks for the fourth consecutive quarter. "magnificent seven" mega-cap technology stocks have outperformed the s&p 500 year-to-date.
Seeking Alpha · 11/15 16:15
Simulations Plus Inc: Current report
Press release · 11/14 19:17
Analysts Are Bullish on These Healthcare Stocks: Simulations Plus (SLP), Celcuity (CELC)
TipRanks · 11/13 14:30
Weekly Report: what happened at SLP last week (1106-1110)?
Weekly Report · 11/13 09:21
Simulations Plus Inc: Statement of changes in beneficial ownership of securities
Press release · 11/09 23:11
More
About SLP
Simulations Plus, Inc. is a provider of modeling and simulation software and services for pharmaceutical drug discovery and development, including the prediction of properties of molecules utilizing both artificial intelligence and machine-based technology. The Company's segments include software and services. It offers 12 software products for pharmaceutical research and development: GastroPlus, DDDPlus, MembranePlus, DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, MonolixSuite, ADMET Predictor and MedChem Designer. Its services include population pharmacokinetic and pharmacodynamic, quantitative systems pharmacology/quantitative systems toxicology, and physiologically based pharmacokinetic. The Company provides consulting services ranging from early drug discovery through preclinical and clinical trial development to regulatory submissions supporting product approval. Its software and consulting services are provided to various industries, including biotechnology and cosmetics.

Webull offers Simulations Plus Inc stock information, including NASDAQ: SLP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SLP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SLP stock methods without spending real money on the virtual paper trading platform.